Viridian Therapeutics, Inc.
VRDNAs of the close on Sep 25, 2026
Price
$20.47
Market cap
$2.32B
P/E (diluted TTM)
—
Per-share earnings are not available for each of the last four quarters
EPS (TTM)
—
Per-share earnings are not available for each of the last four quarters
Dividend yield
—
Dividend records do not yet cover the latest payments
Figures shown here come from public SEC filings. Dates beside each section show the available history.
How Viridian Therapeutics, Inc. Makes Money
Follow each dollar of revenue through to what shareholders keep.
From revenue to net income
Pick a year or quarter. Each band's width is its dollar amount.
Financial Summary
Choose a year or quarter, compare it with the same period a year earlier, and open any row for its full filing history.
Loading financial history…
SEC filings supply these figures; updates after the dates shown are not included. This page includes 13 annual periods. The latest annual period ends Dec 31, 2025. The latest insider filing shown is dated May 13, 2026. The latest institutional report shown is dated Mar 31, 2026; other ownership filings may exist.
Ownership
Who holds the shares, as reported in SEC ownership filings.
Reported 13F positions
Each row shows what a filer reported for one date, not a current position. The link opens that filing.
| Filer | Report date | Shares | Value | Filing |
|---|---|---|---|---|
| Paradigm Biocapital Advisors LP | 2026-03-31 | 3,148,893 | $61.6M | SEC filing |
| SEI INVESTMENTS CO | 2026-03-31 | 65,777 | $1.29M | SEC filing |
| Optiver Holding B.V. | 2026-03-31 | 218 | $4.26K | SEC filing |
| ZIONS BANCORPORATION, NATIONAL ASSOCIATION /UT/ | 2026-03-31 | 90 | $1.76K | SEC filing |
| MARSHALL WACE, LLP | 2026-03-31 | 269,587 | $5.27M | SEC filing |
| PROFUND ADVISORS LLC | 2026-03-31 | 63,341 | $1.24M | SEC filing |
| Keating Financial Advisory Services, Inc. | 2026-03-31 | 1 | $20 | SEC filing |
| ROTHSCHILD INVESTMENT LLC | 2026-03-31 | 136 | $2.66K | SEC filing |
| ALLIANCEBERNSTEIN L.P. | 2026-03-31 | 1,392,072 | Not shown | SEC filing |
| MPM BIOIMPACT LLC | 2026-03-31 | 649,873 | $12.7M | SEC filing |
| State of Wyoming | 2026-03-31 | 4,764 | $93.2K | SEC filing |
| RHUMBLINE ADVISERS | 2026-03-31 | 100,033 | $1.96M | SEC filing |
| MORGAN STANLEY | 2026-03-31 | 870,162 | $17M | SEC filing |
| Allworth Financial LP | 2026-03-31 | 34 | $666 | SEC filing |
| Swiss National Bank | 2026-03-31 | 128,600 | $2.52M | SEC filing |
| Davern Capital Partners, LP | 2026-03-31 | 302,457 | $5.92M | SEC filing |
| PNC FINANCIAL SERVICES GROUP, INC. | 2026-03-31 | 207 | $4.05K | SEC filing |
| OSAIC HOLDINGS, INC. | 2026-03-31 | 830 | $16.2K | SEC filing |
| BNP PARIBAS FINANCIAL MARKETS | 2026-03-31 | 266,399 | $5.21M | SEC filing |
| JPMORGAN CHASE & CO | 2026-03-31 | 1,059,864 | $19.6M | SEC filing |
- Each value is checked against Viridian Therapeutics, Inc.'s share prices from within about three months of its report date (insiders' Form 4 trades and the latest close).
- Value not shown for 1 row: the value per share could not be confirmed against the share prices on file from within three months of the report date.
120 filers have only one report here.
Unusually large insider trades
Each trade is compared with the other insider trades of the same kind in the same security among Viridian Therapeutics, Inc.'s recent filings on file. Size alone is context, not a prediction or evidence of improper trading.
- 2026-05-11 · Fairmount Healthcare Fund II L.P.: Larger than 16 of the 17 other insider purchases of Common Stock on file. SEC filing
- 2024-09-13 · Fairmount Healthcare Fund II L.P.: Larger than all 17 other insider purchases of Common Stock on file. SEC filing
Independent insiders buying near the same time
- 2024-09-27–2024-09-27: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2021-09-21–2021-09-23: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
- 2018-02-13–2018-02-13: 2 event(s) across 2 owner(s) — A cluster counts independent reporting owners that reported purchases within a set time. Co-filers and declared affiliates count once, and duplicate reports of the same event count once. ( filing , filing )
Purchases & sales (open market or private)
| Security | Code | Price | Filing | |||
|---|---|---|---|---|---|---|
| 2026-05-11 | Fairmount Healthcare Fund II L.P. · Director, 10% owner | Common Stock | P — Open market or private purchase | +1,176,470 | 17.00 | SEC filing |
| 2025-12-31 | Tousignant Jennifer · Chief Legal Officer | Common Stock | S — Open market or private sale | −2,272 | 31.16 | SEC filing |
| 2025-10-23 | Fairmount Healthcare Fund II L.P. · Director, 10% owner | Common Stock | P — Open market or private purchase | +454,545 | 22.00 | SEC filing |
| 2024-09-27 | Mahoney Stephen F. · President and CEO | Common Stock | P — Open market or private purchase | +21,400 | 23.33 | SEC filing |
| 2024-09-27 | Beetham Thomas W. · Chief Operating Officer | Common Stock | P — Open market or private purchase | +5,000 | 23.41 | SEC filing |
| 2024-09-13 | Fairmount Healthcare Fund II L.P. · Director, 10% owner | Common Stock | P — Open market or private purchase | +1,600,000 | 18.75 | SEC filing |
| 2024-01-22 | Fairmount Healthcare Fund L.P. · Director, other | Common Stock | P — Open market or private purchase | +476,190 | 21.00 | SEC filing |
| 2023-06-16 | Meisner Lara · Chief Legal Officer | Common Stock | S — Open market or private sale | −27 | 28.35 | SEC filing |
Showing 8 of 20 rows
Grants, exercises, tax & gifts
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2026-03-03 | Tousignant Jennifer · Chief Legal Officer | Common Stock | M — Exercise or conversion of derivative security | +5,169 | SEC filing |
| 2026-03-03 | Beetham Thomas W. · Chief Operating Officer | Common Stock | M — Exercise or conversion of derivative security | +9,409 | SEC filing |
| 2026-03-03 | Beetham Thomas W. · Chief Operating Officer | Restricted Stock Units | M — Exercise or conversion of derivative security | −9,409 | SEC filing |
| 2026-03-03 | Tousignant Jennifer · Chief Legal Officer | Restricted Stock Units | M — Exercise or conversion of derivative security | −5,169 | SEC filing |
| 2026-03-03 | Mahoney Stephen F. · President and CEO | Restricted Stock Units | M — Exercise or conversion of derivative security | −18,357 | SEC filing |
| 2026-03-03 | Harmon Seth · Chief Financial Officer | Common Stock | M — Exercise or conversion of derivative security | +6,267 | SEC filing |
| 2026-03-03 | Harmon Seth · Chief Financial Officer | Restricted Stock Units | M — Exercise or conversion of derivative security | −6,267 | SEC filing |
| 2026-03-03 | Mahoney Stephen F. · President and CEO | Common Stock | M — Exercise or conversion of derivative security | +18,357 | SEC filing |
Showing 8 of 28 rows
Other activity
| Security | Code | Filing | |||
|---|---|---|---|---|---|
| 2024-03-28 | Fairmount Healthcare Fund L.P. · Director | Series A Non-Voting Convertible Preferred Stock | J — Other acquisition or disposition | +21,999 | SEC filing |
| 2024-03-28 | Fairmount Healthcare Fund L.P. · Director | Series A Non-Voting Convertible Preferred Stock | J — Other acquisition or disposition | −21,999 | SEC filing |
| 2024-03-28 | Fairmount Healthcare Fund L.P. · Director | Common Stock | J — Other acquisition or disposition | −5,859 | SEC filing |
| 2024-03-28 | Fairmount Healthcare Fund L.P. · Director | Common Stock | J — Other acquisition or disposition | +5,859 | SEC filing |
| 2020-10-27 | Fairmount Healthcare Fund L.P. · Director, other | Series A Non-Voting Convertible Preferred Stock | J — Other acquisition or disposition | +16,505 | SEC filing |
| 2020-10-27 | Fairmount Healthcare Fund L.P. · Director, other | Series A Non-Voting Convertible Preferred Stock | J — Other acquisition or disposition | +82,349 | SEC filing |
| 2020-10-27 | Violin Jonathan · President and COO | Series A Non-Voting Convertible Preferred Stock | J — Other acquisition or disposition | +9,413 | SEC filing |
| 2020-10-27 | Fairmount Healthcare Fund L.P. · Director, other | Common Stock | J — Other acquisition or disposition | +87,891 | SEC filing |
Showing 8 of 10 rows
These tables describe filed transactions, not current holdings. Prices are shown as filed; a currency is added only when the filing's data names one. Amended and possible duplicate rows are left out of size comparisons and transaction groups.